ALRPD.PA Rapid Nutrition up 50.77% pre-market EURONEXT 09 Feb 2026: volume surge

ALRPD.PA stock is trading at €11.76 pre-market on EURONEXT after a +50.77% one-day move, driven by a volume surge to 57,453 shares versus an average 17,508. The spike pushed the intraday range to €7.51–€12.56, far above the 50-day average €4.03 and 200-day average €5.13. We assess what the jump means for valuation, technical momentum and near-term forecasts while noting the company’s weak earnings history and small market cap in Europe’s healthcare segment.

ALRPD.PA stock price action and liquidity

Rapid Nutrition PLC (ALRPD.PA) opened €8.01 and is trading €11.76 pre-market on EURONEXT with a rel. volume 3.28, signalling above-average demand. The one-day change of +50.77% follows a five-day gain of +104.52% and YTD of +352.31%, showing extreme short-term momentum.

Volume matters here: current 57,453 shares traded exceed the 50-day average of 17,508, which validates the price move but raises short-term volatility and liquidity risk for larger orders.

ALRPD.PA stock catalysts and news

There are no direct company press releases in the feed; recent coverage is comparison and benchmark analysis on Investing.com that may drive screening-based flows source. Fresh headline-driven moves would be needed to sustain momentum.

Sector context: Rapid Nutrition sits in Healthcare—Drug Manufacturers – Specialty & Generic—where sector YTD is -1.63%. A company-specific catalyst is still required to justify a sustained rerating source.

ALRPD.PA stock fundamentals and valuation

Rapid Nutrition reports EPS -22.77 and a quoted PE -0.52, reflecting negative earnings and a loss-making profile. Market cap is small at €5,585,224.00 with 474,934 shares outstanding, so market moves can be amplified by low float.

Price-to-sales and price-to-book ratios are extreme in the data set, and the company shows slim revenue per share €0.00 (rounded) and negative cash flow per share. CurrentRatio 3.57 is healthy, but margins and profitability remain negative, underscoring valuation risk for long-term investors.

ALRPD.PA stock technicals and Meyka grade

Momentum indicators show strength: RSI 64.22 and ADX 27.10 point to a firm short-term trend while CCI 200.34 signals overbought conditions. Price is well above both the 50-day €4.03 and 200-day €5.13, highlighting a sharp breakout from recent averages.

Meyka AI rates ALRPD.PA with a score out of 100: 62.21 (B, HOLD). This grade factors in S&P 500 and sector comparison, financial growth, key metrics and analyst consensus. These grades are not guaranteed and are not financial advice.

ALRPD.PA stock forecasts and price targets

Meyka AI’s forecast model projects a monthly price of €7.20 and a quarterly figure of €0.72. Compared with the current €11.76, the monthly projection implies an -38.78% move and the quarterly projection implies -93.88%. Forecasts are model-based projections and not guarantees.

Practical price targets for traders: conservative target €6.00 (reversion toward 200-day average), base case €11.00 (current consolidation), bullish €18.00 (momentum hold with further catalysts). Targets reflect thin market cap, historical averages and high volatility.

ALRPD.PA stock risks and trading strategy

Key risks: loss-making operations (negative EPS), thin market cap €5.59m, and large swings from small news. Receivables and inventory turnover are weak, and net margins are negative, increasing business risk.

For traders, use tight risk controls: consider smaller position sizes, stop-losses and only allocate a small percentage of a portfolio due to liquidity and volatility. For investors, wait for confirmed revenue growth and stable profitability before increasing exposure.

Final Thoughts

ALRPD.PA stock’s pre-market surge to €11.76 on 09 Feb 2026 exposes a short-term momentum trade but does not change the company’s fundamental profile. The move is supported by a volume spike to 57,453 shares and technical strength (RSI 64.22, ADX 27.10), yet Rapid Nutrition remains loss-making with EPS -22.77 and an unusual valuation picture. Meyka AI’s quantitative view produces a monthly projection of €7.20, implying an estimated -38.78% from today’s level; these model outputs are not guarantees but help frame mean-reversion risk. Our practical price targets: conservative €6.00, base €11.00, bullish €18.00—each calibrated to thin market cap and long-term averages (50-day €4.03, 200-day €5.13). Traders seeking to play the pre-market move should prioritise liquidity, use disciplined stops and treat positions as high-risk. Long-term investors should wait for consistent top-line growth and margin improvements before adding exposure. Find the company page for live updates at Rapid Nutrition PLC on Meyka.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.